form_type
stringclasses 2
values | accession_number
stringlengths 20
20
| filing_date
stringlengths 14
14
| quarter_ending
stringclasses 172
values | company_name
stringlengths 5
54
| text
stringlengths 101
2.42k
| entities
listlengths 1
18
|
|---|---|---|---|---|---|---|
10-Q | 0001699136-23-000067 | 20230510171822 | 20230331 | Cactus, Inc. | From acquisition date through March 31, 2023, FlexSteel had revenue of $33.8 million and net income of $0.4 million. The pro forma financial information below represents the combined results of operations for the three months ended March 31, 2023 and 2022, as if the acquisition had occurred as of January 1, 2022. The unaudited pro forma combined financial information includes, where applicable, adjustments for additional amortization expense related to the fair value step-up of intangible assets, additional inventory fair value step-up expense, additional depreciation expense associated with adjusting property and equipment to fair value, changes to align accounting policies, decreases in interest expense due to modification of borrowings in conjunction with the acquisition and associated tax-related impacts of adjustments. These pro forma adjustments are based on available information as of the date hereof and upon assumptions that we believe are reasonable to reflect the impact of the FlexSteel acquisition on our historical financial information on a supplemental pro forma basis. Adjustments do not include the elimination of transaction-related costs incurred or any costs related to integration activities, cost savings or synergies that have been or may | [
{
"currency_/_unit": "USD",
"end_character": 76,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 72,
"start_date_for_period": "2023-01-01",
"value": 33800000
},
{
"currency_/_unit": "USD",
"end_character": 107,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 104,
"start_date_for_period": "2023-01-01",
"value": 400000
}
] |
10-Q | 0000733076-23-000006 | 20230511160945 | 20230331 | BRIGHTHOUSE LIFE INSURANCE Co | Brighthouse Services, LLC, an affiliate, currently provides the Company certain services, which include, but are not limited to, treasury, financial planning and analysis, legal, human resources, tax planning, internal audit, financial reporting and information technology. Revenues received from an affiliate related to these agreements, recorded in universal life and investment-type product policy fees, were $44 million and $54 million for the three months ended March 31, 2023 and 2022, respectively. Costs incurred under these arrangements were $226 million and $223 million for the three months ended March 31, 2023 and 2022, respectively, and were recorded in other expenses. | [
{
"currency_/_unit": "USD",
"end_character": 415,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 413,
"start_date_for_period": "2023-01-01",
"value": 44000000
},
{
"currency_/_unit": "USD",
"end_character": 431,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 429,
"start_date_for_period": "2022-01-01",
"value": 54000000
},
{
"currency_/_unit": "USD",
"end_character": 555,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 552,
"start_date_for_period": "2023-01-01",
"value": 226000000
},
{
"currency_/_unit": "USD",
"end_character": 572,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 569,
"start_date_for_period": "2022-01-01",
"value": 223000000
}
] |
10-Q | 0000733076-23-000006 | 20230511160945 | 20230331 | BRIGHTHOUSE LIFE INSURANCE Co | The related party expense for the Company was commissions paid on the sale of variable products and passed through to the broker-dealer affiliate. The related party revenue for the Company was fee income passed through the broker-dealer affiliate from trusts and mutual funds whose shares serve as investment options of policyholders of the Company. Fee income received related to these transactions and recorded in other revenues was $42 million and $52 million for the three months ended March 31, 2023 and 2022, respectively. Commission expenses incurred related to these transactions and recorded in other expenses was $225 million and $230 million for the three months ended March 31, 2023 and 2022, respectively. The Company also had related party fee income receivables of $14 million at both March 31, 2023 | [
{
"currency_/_unit": "USD",
"end_character": 438,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 436,
"start_date_for_period": "2023-01-01",
"value": 42000000
},
{
"currency_/_unit": "USD",
"end_character": 454,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 452,
"start_date_for_period": "2022-01-01",
"value": 52000000
},
{
"currency_/_unit": "USD",
"end_character": 627,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 624,
"start_date_for_period": "2023-01-01",
"value": 225000000
},
{
"currency_/_unit": "USD",
"end_character": 644,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 641,
"start_date_for_period": "2022-01-01",
"value": 230000000
}
] |
10-Q | 0001493152-23-017381 | 20230515161633 | 20230331 | MALACHITE INNOVATIONS, INC. | The
accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement
of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, during the three
months ended March 31, 2023, the Company incurred a net loss of $226,860 and $675,796 of cash was provided by the Company’s operating
activities. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of
the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary should
the Company be unable to continue as a going concern. | [
{
"currency_/_unit": "USD",
"end_character": 356,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 349,
"start_date_for_period": "2023-01-01",
"value": -226860
},
{
"currency_/_unit": "USD",
"end_character": 369,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 362,
"start_date_for_period": "2023-01-01",
"value": 675796
}
] |
10-Q | 0001493152-23-015784 | 20230508160544 | 20230331 | OVERSEAS SHIPHOLDING GROUP INC | The
Company is the lessor under its time charter contracts. Total time charter revenue was equal to income from lease payments of $84,434
less straight-line adjustments of $294 for the three months ended March 31, 2023. For the three months ended March 31, 2022, total time
charter revenue was equal to income from lease payments of $56,909 plus straight-line adjustments of $327. | [
{
"currency_/_unit": "USD",
"end_character": 137,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 131,
"start_date_for_period": "2023-01-01",
"value": 84434000
},
{
"currency_/_unit": "USD",
"end_character": 176,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 173,
"start_date_for_period": "2023-01-01",
"value": 294000
},
{
"currency_/_unit": "USD",
"end_character": 340,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 334,
"start_date_for_period": "2022-01-01",
"value": 56909000
},
{
"currency_/_unit": "USD",
"end_character": 379,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 376,
"start_date_for_period": "2022-01-01",
"value": 327000
}
] |
10-Q | 0001650372-23-000024 | 20230505160642 | 20230331 | Atlassian Corp | The Company reported an income tax provision of $53.6 million on pretax loss of $155.4 million and an income tax provision of $162.1 million on pretax loss of $265.7 million for the three and nine months ended March 31, 2023, respectively, as compared to an income tax provision of $1.6 million on pretax income of $6.3 million and an income tax provision of $4.3 million on pretax loss of $424.6 million for the three and nine months ended March 31, 2022, respectively. The income tax provision for the three and nine months ended March 31, 2023 reflects an increase in tax expense primarily attributable to the recognition of a reserve for uncertain tax positions and overall growth in foreign jurisdictions associated with an increase in profit and non-deductible stock-based compensation. The Company’s effective tax rate substantially differed from the U.S. statutory income tax rate of 21.0% primarily due to the recognition of a reserve for uncertain tax positions, different tax rates, non-deductible stock-based compensation in foreign jurisdictions, in addition to full valuation allowances in the U.S. and Australia. | [
{
"currency_/_unit": "USD",
"end_character": 53,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 49,
"start_date_for_period": "2023-01-01",
"value": 53600000
},
{
"currency_/_unit": "USD",
"end_character": 86,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 81,
"start_date_for_period": "2023-01-01",
"value": -155400000
},
{
"currency_/_unit": "USD",
"end_character": 132,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 127,
"start_date_for_period": "2022-07-01",
"value": 162100000
},
{
"currency_/_unit": "USD",
"end_character": 165,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 160,
"start_date_for_period": "2022-07-01",
"value": -265700000
},
{
"currency_/_unit": "USD",
"end_character": 286,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 283,
"start_date_for_period": "2022-01-01",
"value": 1600000
},
{
"currency_/_unit": "USD",
"end_character": 319,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 316,
"start_date_for_period": "2022-01-01",
"value": 6300000
},
{
"currency_/_unit": "USD",
"end_character": 363,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 360,
"start_date_for_period": "2021-07-01",
"value": 4300000
},
{
"currency_/_unit": "USD",
"end_character": 396,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 391,
"start_date_for_period": "2021-07-01",
"value": -424600000
}
] |
10-Q | 0000008868-23-000011 | 20230515123628 | 20230331 | AVON PRODUCTS INC | Total revenue also includes revenue from other business activities of $0.1 and $0.1 for the three months ended March 31, 2023 and 2022, respectively, allocated to Avon International and Avon Latin America segments. Other business activities include revenue from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. | [
{
"currency_/_unit": "USD",
"end_character": 74,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 71,
"start_date_for_period": "2023-01-01",
"value": 100000
},
{
"currency_/_unit": "USD",
"end_character": 83,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 80,
"start_date_for_period": "2023-01-01",
"value": 100000
}
] |
10-Q | 0000008868-23-000011 | 20230515123628 | 20230331 | AVON PRODUCTS INC | Total profit (loss) from reportable segments also includes profit from other business activities and central expenses allocated to Avon International and Avon Latin America segments. Other business activities of $0.1 and $0.1 for the three months ended March 31, 2023 and 2022, respectively, include profit from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Central expenses of $24.4 and $29.0 for the three months ended March 31, 2023 and 2022, respectively, include corporate general and administrative expenses allocated to Avon International and Avon Latin America to the extent they support the operating activity of the segment. | [
{
"currency_/_unit": "USD",
"end_character": 216,
"end_date_for_period": "2023-03-31",
"label": "ebit",
"start_character": 213,
"start_date_for_period": "2023-01-01",
"value": 100000
},
{
"currency_/_unit": "USD",
"end_character": 225,
"end_date_for_period": "2023-03-31",
"label": "ebit",
"start_character": 222,
"start_date_for_period": "2023-01-01",
"value": 100000
},
{
"currency_/_unit": "USD",
"end_character": 529,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 525,
"start_date_for_period": "2023-01-01",
"value": 24400000
},
{
"currency_/_unit": "USD",
"end_character": 539,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 535,
"start_date_for_period": "2022-01-01",
"value": 29000000
}
] |
10-Q | 0001628280-23-017000 | 20230509203644 | 20230331 | PetIQ, Inc. | The computation of dilutive effect of other potential common shares includes 0 and 60 for stock options as well as 45 and 66 restricted stock units for the three months ended March 31, 2023 and 2022, respectively. All stock options and 693 thousand restricted stock units have been excluded from the computation of dilutive effect as they are antidilutive for the three months ended March 31, 2023. For the three months ended March 31, 2022 stock awards of 1,797 thousand shares were excluded from the computation of dilutive effect as they were antidilutive. | [
{
"currency_/_unit": "shares",
"end_character": 78,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 77,
"start_date_for_period": "2023-01-01",
"value": 0
},
{
"currency_/_unit": "shares",
"end_character": 85,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 83,
"start_date_for_period": "2022-01-01",
"value": 60000
},
{
"currency_/_unit": "shares",
"end_character": 117,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 115,
"start_date_for_period": "2023-01-01",
"value": 45000
},
{
"currency_/_unit": "shares",
"end_character": 124,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 122,
"start_date_for_period": "2022-01-01",
"value": 66000
},
{
"currency_/_unit": "shares",
"end_character": 239,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 236,
"start_date_for_period": "2023-01-01",
"value": 693000
},
{
"currency_/_unit": "shares",
"end_character": 463,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 458,
"start_date_for_period": "2022-01-01",
"value": 1797000
}
] |
10-Q | 0001031296-23-000032 | 20230427164754 | 20230331 | FIRSTENERGY CORP | Other revenue unrelated to contracts with customers includes revenue from late payment charges of $11 million and $10 million for the three months ended March 31, 2023 and 2022, respectively. Other revenue unrelated to contracts with customers also includes revenue from derivatives of $6 million and $9 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 101,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 99,
"start_date_for_period": "2023-01-01",
"value": 11000000
},
{
"currency_/_unit": "USD",
"end_character": 117,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 115,
"start_date_for_period": "2022-01-01",
"value": 10000000
},
{
"currency_/_unit": "USD",
"end_character": 288,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 287,
"start_date_for_period": "2023-01-01",
"value": 6000000
},
{
"currency_/_unit": "USD",
"end_character": 303,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 302,
"start_date_for_period": "2022-01-01",
"value": 9000000
}
] |
10-Q | 0001403431-23-000028 | 20230509163526 | 20230331 | Heritage-Crystal Clean, Inc. | Intersegment revenues for the first quarter of fiscal 2023 and fiscal 2022 in the Industrial and Field services segment were $2.5 million and $1.9 million, respectively. The Environmental Services segment and the Oil Business segment had no intersegment revenues for the first quarter of fiscal 2023 and fiscal 2022. | [
{
"currency_/_unit": "USD",
"end_character": 129,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 126,
"start_date_for_period": "2023-01-01",
"value": 2500000
},
{
"currency_/_unit": "USD",
"end_character": 146,
"end_date_for_period": "2022-03-26",
"label": "revenues",
"start_character": 143,
"start_date_for_period": "2022-01-02",
"value": 1900000
}
] |
10-Q | 0001628280-23-015452 | 20230504073258 | 20230331 | MGP INGREDIENTS INC | Participating securities included 227,810 and 189,297 unvested restricted stock units (“RSUs”) at March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "shares",
"end_character": 41,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 34,
"start_date_for_period": "2023-01-01",
"value": 227810
},
{
"currency_/_unit": "shares",
"end_character": 53,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 46,
"start_date_for_period": "2022-01-01",
"value": 189297
}
] |
10-Q | 0001013857-23-000075 | 20230426161202 | 20230331 | PEGASYSTEMS INC | (2) The shares underlying the conversion options in the Company’s Notes are included using the if-converted method, if dilutive in the period. If the outstanding conversion options were fully exercised, the Company would issue approximately 4.2 million shares as of March 31, 2023. | [
{
"currency_/_unit": "shares",
"end_character": 244,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 241,
"start_date_for_period": "2023-01-01",
"value": 4200000
}
] |
10-Q | 0001065280-23-000120 | 20230421160201 | 20230331 | NETFLIX INC | Total U.S. revenues, inclusive of DVD revenues not reported in the tables above, were $3.3 billion and $3.1 billion for the three months ended March 31, 2023 and 2022, respectively. DVD revenues were $32 million and $40 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 90,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 87,
"start_date_for_period": "2023-01-01",
"value": 3300000000
},
{
"currency_/_unit": "USD",
"end_character": 107,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 104,
"start_date_for_period": "2022-01-01",
"value": 3100000000
},
{
"currency_/_unit": "USD",
"end_character": 204,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 202,
"start_date_for_period": "2023-01-01",
"value": 32000000
},
{
"currency_/_unit": "USD",
"end_character": 220,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 218,
"start_date_for_period": "2022-01-01",
"value": 40000000
}
] |
10-Q | 0001065280-23-000120 | 20230421160201 | 20230331 | NETFLIX INC | Total U.S. revenues were $3.3 billion and $3.1 billion for the three months ended March 31, 2023 and 2022, respectively. See Note 2 | [
{
"currency_/_unit": "USD",
"end_character": 29,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 26,
"start_date_for_period": "2023-01-01",
"value": 3300000000
},
{
"currency_/_unit": "USD",
"end_character": 46,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 43,
"start_date_for_period": "2022-01-01",
"value": 3100000000
}
] |
10-Q | 0001493152-23-015555 | 20230505133824 | 20230331 | Accustem Sciences Inc. | Liquidity and Going Concern
The condensed consolidated financial statements have been prepared on the going concern basis, which contemplates the realization of
assets and discharge of liabilities in the normal course of business. The Company has financed its activities principally from
support from a related party. The Company has incurred a net loss in every fiscal period since inception. For the three months ended
March 31, 2023, the Company incurred a net loss of $833,341. The Company has an accumulated deficit of $5,304,622 as of March 31, 2023.
The Company anticipates operating losses to continue for the foreseeable future due to, among other things, costs related to research
funding, further development of its technology and products, and expenses related to the commercialization of its products. | [
{
"currency_/_unit": "USD",
"end_character": 482,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 475,
"start_date_for_period": "2023-01-01",
"value": -833341
},
{
"currency_/_unit": "USD",
"end_character": 536,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 527,
"start_date_for_period": "2023-03-31",
"value": -5304622
}
] |
10-Q | 0000023197-23-000035 | 20230608161026 | 20230430 | COMTECH TELECOMMUNICATIONS CORP /DE/ | Weighted average stock options, RSUs and restricted stock outstanding of 956,000 and 1,369,000 for the three months ended April 30, 2023 and 2022, respectively, and 1,001,000 and 1,463,000 shares for the nine months ended April 30, 2023 and 2022, respectively, were not included in our diluted EPS calculation because their effect would have been anti-dilutive. Our EPS calculations exclude 429,000 and 339,000 weighted average performance shares outstanding for the three months ended April 30, 2023 and 2022, respectively, and 384,000 and 287,000 for the nine months ended April 30, 2023 and 2022, respectively, as the performance conditions have not yet been satisfied. However, the numerator for EPS calculations for each respective period is reduced by the compensation expense related to these awards. | [
{
"currency_/_unit": "shares",
"end_character": 80,
"end_date_for_period": "2023-04-30",
"label": "XBRL-OOS",
"start_character": 73,
"start_date_for_period": "2023-02-01",
"value": 956000
},
{
"currency_/_unit": "shares",
"end_character": 94,
"end_date_for_period": "2022-04-30",
"label": "XBRL-OOS",
"start_character": 85,
"start_date_for_period": "2022-02-01",
"value": 1369000
},
{
"currency_/_unit": "shares",
"end_character": 174,
"end_date_for_period": "2023-04-30",
"label": "XBRL-OOS",
"start_character": 165,
"start_date_for_period": "2022-08-01",
"value": 1001000
},
{
"currency_/_unit": "shares",
"end_character": 188,
"end_date_for_period": "2022-04-30",
"label": "XBRL-OOS",
"start_character": 179,
"start_date_for_period": "2021-08-01",
"value": 1463000
},
{
"currency_/_unit": "shares",
"end_character": 398,
"end_date_for_period": "2023-04-30",
"label": "eps",
"start_character": 391,
"start_date_for_period": "2023-02-01",
"value": 429000
},
{
"currency_/_unit": "shares",
"end_character": 410,
"end_date_for_period": "2022-04-30",
"label": "eps",
"start_character": 403,
"start_date_for_period": "2022-02-01",
"value": 339000
},
{
"currency_/_unit": "shares",
"end_character": 536,
"end_date_for_period": "2023-04-30",
"label": "eps",
"start_character": 529,
"start_date_for_period": "2022-08-01",
"value": 384000
},
{
"currency_/_unit": "shares",
"end_character": 548,
"end_date_for_period": "2022-04-30",
"label": "eps",
"start_character": 541,
"start_date_for_period": "2021-08-01",
"value": 287000
}
] |
10-Q | 0001856365-23-000016 | 20230515173124 | 20230331 | Finwise Bancorp | During the third quarter of 2022, the Company identified an error in the calculation of the Company’s tax provision which understated income tax expense for previously reported financial statements. The error was related to an incorrect application of Section 162(m) of the Internal Revenue Code, which limits tax deductions relating to executive compensation of certain executives of publicly held companies. The Company recorded an out-of-period adjustment during the third quarter of 2022 to correct the previously understated income tax expense. The adjustment resulted in a decrease to after-tax income of $(0.9) million for the year ended December 31, 2022. The impact associated with this correction was not considered material to the interim unaudited consolidated financial statements for the three months ended September 30, 2022, year ended December 31, 2022, or the financial statements of any previously filed interim or annual periods. | [
{
"currency_/_unit": "USD",
"end_character": 616,
"end_date_for_period": "2022-12-31",
"label": "earnings",
"start_character": 613,
"start_date_for_period": "2022-01-01",
"value": -900000
}
] |
10-Q | 0001603923-23-000102 | 20230426163052 | 20230331 | Weatherford International plc | We lease drilling tools, artificial lift pumping equipment and other unmanned equipment to customers as operating leases. These equipment rental revenues are generally provided based on call-out work orders that include fixed per unit prices and are derived from short-term contracts. Equipment rental revenues were $33 million for the three months ended March 31, 2023 and $31 million for the three months ended March 31, 2022. | [
{
"currency_/_unit": "USD",
"end_character": 319,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 317,
"start_date_for_period": "2023-01-01",
"value": 33000000
},
{
"currency_/_unit": "USD",
"end_character": 363,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 361,
"start_date_for_period": "2022-01-01",
"value": 31000000
}
] |
10-Q | 0001603923-23-000102 | 20230426163052 | 20230331 | Weatherford International plc | Corporate and other was a net expense of $3 million in the three months ended March 31, 2023 compared to $14 million in the three months ended March 31, 2022. The year-over-year decrease was primarily due to improved results in other non-core businesses that did not individually meet the criteria for segment reporting and from our focus on cost control and efficiency. | [
{
"currency_/_unit": "USD",
"end_character": 108,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 106,
"start_date_for_period": "2022-01-01",
"value": -14000000
}
] |
10-Q | 0001431695-23-000019 | 20230509164012 | 20230331 | Olo Inc. | Sublease income was $0.7 million and $0.1 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 24,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 21,
"start_date_for_period": "2023-01-01",
"value": 700000
},
{
"currency_/_unit": "USD",
"end_character": 41,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 38,
"start_date_for_period": "2022-01-01",
"value": 100000
}
] |
10-Q | 0001579241-23-000023 | 20230426061006 | 20230331 | Allegion plc | Due to a reporting change effective January 1, 2023, results for the Company's Global Portable Security brands (inclusive of the AXA, Kryptonite and Trelock businesses) are now fully reflected within the Allegion International segment. Accordingly, the summary of operations by reportable segment below for the three months ended March 31, 2022, has been recast to conform with the current year presentation. The impact of this recast was to re-align approximately $6.3 million and $1.3 million of Net revenues and Segment operating income, respectively, from the Allegion Americas segment to the Allegion International segment. | [
{
"currency_/_unit": "USD",
"end_character": 469,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 466,
"start_date_for_period": "2022-01-01",
"value": 6300000
},
{
"currency_/_unit": "USD",
"end_character": 486,
"end_date_for_period": "2022-03-31",
"label": "ebit",
"start_character": 483,
"start_date_for_period": "2022-01-01",
"value": 1300000
}
] |
10-Q | 0001493152-23-017046 | 20230515111326 | 20230331 | YCQH Agricultural Technology Co. Ltd | For
the three months ended March 31, 2023, the Company generated total revenue of $154,294, of which one customer accounted for more than
10% of the Company’s total revenue. For the three months ended March 31, 2022, the Company generated total revenue of $13,962,
of which three customers accounted for the Company’s entire revenue. | [
{
"currency_/_unit": "USD",
"end_character": 263,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 257,
"start_date_for_period": "2022-01-01",
"value": 13962
}
] |
10-Q | 0001038509-23-000012 | 20230511163617 | 20230331 | PRUCO LIFE INSURANCE OF NEW JERSEY | The Company pays commissions and certain other fees to Prudential Annuities Distributors, Inc. (“PAD”) in consideration for PAD’s marketing and underwriting of the Company’s annuity products. Commissions and fees are paid by PAD to broker-dealers who sell the Company’s annuity products. Commissions and fees paid by the Company to PAD were $8 million and $12 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 343,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 342,
"start_date_for_period": "2023-01-01",
"value": 8000000
},
{
"currency_/_unit": "USD",
"end_character": 359,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 357,
"start_date_for_period": "2022-01-01",
"value": 12000000
}
] |
10-Q | 0001493152-23-017365 | 20230515161614 | 20230331 | Belpointe PREP, LLC | For
the three months ended March 31, 2023, the basic and diluted weighted-average units outstanding were 3,523,449. For the three months
ended March 31, 2023, net loss attributable to Class A units was $2.8 million, and the loss per basic and diluted unit was $0.80. | [
{
"currency_/_unit": "USD",
"end_character": 206,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 203,
"start_date_for_period": "2023-01-01",
"value": 2800000
}
] |
10-Q | 0001493152-23-017365 | 20230515161614 | 20230331 | Belpointe PREP, LLC | For
the three months ended March 31, 2022, the basic and diluted weighted-average units outstanding were 3,382,149. For the three months
ended March 31, 2022, net loss attributable to Class A units was $2.0 million, and the loss per basic and diluted unit was $0.60. | [
{
"currency_/_unit": "USD",
"end_character": 206,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 203,
"start_date_for_period": "2022-01-01",
"value": 2000000
}
] |
10-Q | 0000831547-23-000012 | 20230511160303 | 20230331 | SPECTRUM PHARMACEUTICALS INC | Through May 15, 2023, $15.0 million (the “Term C Loan”) if we provide satisfactory evidence that we have achieved a minimum of $15.7 million in Net Product Revenue (as defined in the Loan Agreement) calculated on a trailing six | [
{
"currency_/_unit": "USD",
"end_character": 27,
"end_date_for_period": "2023-05-15",
"label": "XBRL-OOS",
"start_character": 23,
"start_date_for_period": "2023-05-15",
"value": 15000000
},
{
"currency_/_unit": "USD",
"end_character": 132,
"end_date_for_period": "2023-05-15",
"label": "revenues",
"start_character": 128,
"start_date_for_period": "2022-09-22",
"value": 15700000
}
] |
10-Q | 0000831547-23-000012 | 20230511160303 | 20230331 | SPECTRUM PHARMACEUTICALS INC | Through November 15, 2023, $10.0 million (the “Term D Loan”) if we provide satisfactory evidence that we have achieved a minimum of $40.0 million in Net Product Revenue calculated on a trailing six (6) month basis for any measuring period ending on or prior to September 30, 2023. | [
{
"currency_/_unit": "USD",
"end_character": 32,
"end_date_for_period": "2023-11-15",
"label": "XBRL-OOS",
"start_character": 28,
"start_date_for_period": "2023-11-15",
"value": 10000000
},
{
"currency_/_unit": "USD",
"end_character": 137,
"end_date_for_period": "2023-09-30",
"label": "revenues",
"start_character": 133,
"start_date_for_period": "2023-09-30",
"value": 40000000
}
] |
10-Q | 0001493152-23-017426 | 20230515163046 | 20230331 | Sun Pacific Holding Corp. | The
accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the
United States of America, assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction
of liabilities in the normal course of business. For the three months ended March 31, 2023 and 2022, the Company incurred losses from
operations of $90,971 and $28,370, respectively. The Company had a working capital deficit of $3,227,085 as of March 31, 2023. These
circumstances raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to
continue as a going concern is dependent on its ability to raise the additional capital to meet short and long-term operating requirements.
Management is continuing to pursue external financing alternatives to improve the Company’s working capital position however additional
financing may not be available upon acceptable terms, or at all. If the Company is unable to obtain the necessary capital, the Company
may have to cease operations. | [
{
"currency_/_unit": "USD",
"end_character": 435,
"end_date_for_period": "2023-03-31",
"label": "ebit",
"start_character": 429,
"start_date_for_period": "2023-01-01",
"value": -90971
},
{
"currency_/_unit": "USD",
"end_character": 447,
"end_date_for_period": "2022-03-31",
"label": "ebit",
"start_character": 441,
"start_date_for_period": "2022-01-01",
"value": -28370
},
{
"currency_/_unit": "USD",
"end_character": 518,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 509,
"start_date_for_period": "2023-03-31",
"value": -3227085
}
] |
10-Q | 0001493152-23-015301 | 20230503160605 | 20230331 | Decentral Life, Inc. | The
Company’s related party revenue for three months ended March 31, 2023 and 2022, were $142,775 and $-0-, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 97,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 90,
"start_date_for_period": "2023-01-01",
"value": 142775
},
{
"currency_/_unit": "USD",
"end_character": 105,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 104,
"start_date_for_period": "2022-01-01",
"value": 0
}
] |
10-Q | 0001285550-23-000046 | 20230511171736 | 20230331 | ClearPoint Neuro, Inc. | During the three months ended March 31, 2023, the Company recognized approximately $0.3 million of revenue, which was previously included in deferred revenue in the accompanying condensed consolidated balance sheet at December 31, 2022. | [
{
"currency_/_unit": "USD",
"end_character": 87,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 84,
"start_date_for_period": "2023-01-01",
"value": 300000
}
] |
10-Q | 0001493152-23-016516 | 20230512092452 | 20230331 | LifeMD, Inc. | Total
revenue for LifeMD PC was approximately $358 thousand and $0 for the three months ended March 31, 2023 and 2022, respectively. Total
net loss for LifeMD PC was approximately $1.0 million and $1.5 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 50,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 47,
"start_date_for_period": "2023-01-01",
"value": 358000
},
{
"currency_/_unit": "USD",
"end_character": 184,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 181,
"start_date_for_period": "2023-01-01",
"value": 1000000
},
{
"currency_/_unit": "USD",
"end_character": 201,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 198,
"start_date_for_period": "2022-01-01",
"value": 1500000
}
] |
10-Q | 0001628280-23-016643 | 20230509085529 | 20230331 | Mersana Therapeutics, Inc. | The Company has incurred cumulative net losses since inception. For the three months ended March 31, 2023, the net loss was $56.2 million, compared to $47.3 million in the three months ended March 31, 2022. The Company expects to continue to incur operating losses for at least the next several years. As of March 31, 2023, the Company had an accumulated deficit of $710.9 million. The future success of the Company is dependent on, among other factors, its ability to identify and develop its product candidates and ultimately upon its ability to attain profitable operations. The Company has devoted substantially all of its financial resources and efforts to research and development and general and administrative expense to support such research and development. Net losses and negative operating cash flows have had, and will continue to have, an adverse effect on the Company’s stockholders' equity and working capital. | [
{
"currency_/_unit": "USD",
"end_character": 129,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 125,
"start_date_for_period": "2023-01-01",
"value": -56200000
},
{
"currency_/_unit": "USD",
"end_character": 156,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 152,
"start_date_for_period": "2022-01-01",
"value": -47300000
},
{
"currency_/_unit": "USD",
"end_character": 372,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 367,
"start_date_for_period": "2023-03-31",
"value": -710900000
}
] |
10-Q | 0001516551-23-000041 | 20230511195315 | 20230331 | Skye Bioscience, Inc. | The Company has incurred operating losses and negative cash flows from operations since inception and as of March 31, 2023, had a working capital deficit of $4,916,609 and an accumulated deficit of $71,905,285. As of March 31, 2023, the Company had unrestricted cash in the amount of $2,668,697. For the three months ended March 31, 2023 and 2022, the Company incurred losses from operations of $3,100,158 and $2,888,021, respectively. For the three months ended March 31, 2023 and 2022, the Company incurred net losses of $5,167,520 and $3,043,399, respectively. The Company expects to continue to incur significant losses through the end of 2023 and expects to incur significant losses and negative cash flows from operations in the future. | [
{
"currency_/_unit": "USD",
"end_character": 167,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 158,
"start_date_for_period": "2023-03-31",
"value": -4916609
},
{
"currency_/_unit": "USD",
"end_character": 209,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 199,
"start_date_for_period": "2023-03-31",
"value": -71905285
},
{
"currency_/_unit": "USD",
"end_character": 294,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 285,
"start_date_for_period": "2023-03-31",
"value": 2668697
},
{
"currency_/_unit": "USD",
"end_character": 405,
"end_date_for_period": "2023-03-31",
"label": "ebit",
"start_character": 396,
"start_date_for_period": "2023-01-01",
"value": -3100158
},
{
"currency_/_unit": "USD",
"end_character": 420,
"end_date_for_period": "2022-03-31",
"label": "ebit",
"start_character": 411,
"start_date_for_period": "2022-01-01",
"value": -2888021
},
{
"currency_/_unit": "USD",
"end_character": 533,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 524,
"start_date_for_period": "2023-01-01",
"value": -5167520
},
{
"currency_/_unit": "USD",
"end_character": 548,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 539,
"start_date_for_period": "2022-01-01",
"value": -3043399
}
] |
10-Q | 0001468666-23-000022 | 20230608160323 | 20230505 | SecureWorks Corp | Because the Company is included in the tax filings of other Dell entities, management has determined that it will be able to realize the remainder of its deferred tax assets. If the Company becomes ineligible for inclusion in the Dell Technologies consolidated tax group, its ability to benefit from its losses and other tax attributes may be impaired as it would need to file its own Federal and State tax returns without the ability to offset its losses against the profits from the parent. The Company may be required to record a valuation allowance against its deferred tax assets that are currently recorded based on the tax sharing agreement with Dell. Currently, net deferred tax assets are approximately $5.9 million. If the Company’s tax provision had been prepared using the separate return method, the unaudited pro forma pre-tax loss, tax benefit and net loss for the three months ended May 5, 2023 would have been $38.1 million, $1.0 million and $37.1 million, respectively, as a result of the recognition of a valuation allowance that would have been recorded on a significant amount of deferred tax assets as well as certain attributes from the Tax Cuts and Jobs Act of 2017 that would be lost if not utilized by the Dell consolidated group. | [
{
"currency_/_unit": "USD",
"end_character": 716,
"end_date_for_period": "2023-05-05",
"label": "XBRL-OOS",
"start_character": 713,
"start_date_for_period": "2023-05-05",
"value": 5900000
},
{
"currency_/_unit": "USD",
"end_character": 932,
"end_date_for_period": "2023-05-05",
"label": "earnings",
"start_character": 928,
"start_date_for_period": "2023-02-04",
"value": 38100000
},
{
"currency_/_unit": "USD",
"end_character": 946,
"end_date_for_period": "2023-05-05",
"label": "XBRL-OOS",
"start_character": 943,
"start_date_for_period": "2023-02-04",
"value": 1000000
},
{
"currency_/_unit": "USD",
"end_character": 964,
"end_date_for_period": "2023-05-05",
"label": "earnings",
"start_character": 960,
"start_date_for_period": "2023-02-04",
"value": 37100000
}
] |
10-Q | 0001794783-23-000049 | 20230510163315 | 20230331 | SelectQuote, Inc. | 2021, and March 31, 2022, respectively. Accounts receivable was misstated by $10.0 million and $2.2 million as of June 30, 2021 and 2020, respectively. The impact of the cumulative misstatements on net income for the years ended June 30, 2021 and 2020, were decreases of $6.2 million and $1.7 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 82,
"end_date_for_period": "2021-06-30",
"label": "XBRL-OOS",
"start_character": 78,
"start_date_for_period": "2021-06-30",
"value": 10000000
},
{
"currency_/_unit": "USD",
"end_character": 99,
"end_date_for_period": "2020-06-30",
"label": "XBRL-OOS",
"start_character": 96,
"start_date_for_period": "2020-06-30",
"value": -2200000
},
{
"currency_/_unit": "USD",
"end_character": 275,
"end_date_for_period": "2021-06-30",
"label": "earnings",
"start_character": 272,
"start_date_for_period": "2020-07-01",
"value": -6200000
},
{
"currency_/_unit": "USD",
"end_character": 292,
"end_date_for_period": "2020-06-30",
"label": "earnings",
"start_character": 289,
"start_date_for_period": "2019-07-01",
"value": -1700000
}
] |
10-Q | 0000750004-23-000014 | 20230509170414 | 20230331 | Light & Wonder, Inc. | For the three months ended March 31, 2023, we included 2 million of common stock equivalents in the calculation of diluted net income attributable to L&W per share. Basic and diluted net income attributable to L&W per share were the same for the three months ended March 31, 2022, as all common stock equivalents would have been anti-dilutive for that period. We excluded 2 million of stock options and 3 million of RSUs outstanding as of March 31, 2022 from the calculation of diluted weighted-average common shares outstanding for the three months ended March 31, 2022. | [
{
"currency_/_unit": "shares",
"end_character": 38,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 37,
"start_date_for_period": "2023-01-01",
"value": 2000000
},
{
"currency_/_unit": "shares",
"end_character": 40,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 39,
"start_date_for_period": "2023-01-01",
"value": 2000000
},
{
"currency_/_unit": "shares",
"end_character": 41,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 40,
"start_date_for_period": "2022-01-01",
"value": 3000000
}
] |
10-Q | 0000750004-23-000014 | 20230509170414 | 20230331 | Light & Wonder, Inc. | The amount of rental income revenue that is outside the scope of ASC 606 was $117 million and $113 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 81,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 78,
"start_date_for_period": "2023-01-01",
"value": 117000000
},
{
"currency_/_unit": "USD",
"end_character": 98,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 95,
"start_date_for_period": "2022-01-01",
"value": 113000000
}
] |
10-Q | 0001628280-23-017012 | 20230510060558 | 20230331 | Verano Holdings Corp. | Also, the Investment in Associates was corrected to account for distributions in excess of investment resulting in an increase of Equity Income of $1,638 at March 31, 2022, with a reduction in Disposition of Investments of $3,176 at March 31, 2022. | [
{
"currency_/_unit": "USD",
"end_character": 153,
"end_date_for_period": "2022-03-31",
"label": "ebit",
"start_character": 148,
"start_date_for_period": "2022-01-01",
"value": 1638000
},
{
"currency_/_unit": "USD",
"end_character": 229,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 224,
"start_date_for_period": "2022-01-01",
"value": -3176000
}
] |
10-Q | 0000766704-23-000017 | 20230503073226 | 20230331 | WELLTOWER INC. | , we recognized $384,059,000 of rental income related to operating leases, of which $53,794,000 was for variable lease payments that primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. For the three months ended March 31, 2022, we recognized | [
{
"currency_/_unit": "USD",
"end_character": 28,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 17,
"start_date_for_period": "2023-01-01",
"value": 384059000
},
{
"currency_/_unit": "USD",
"end_character": 95,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 85,
"start_date_for_period": "2023-01-01",
"value": 53794000
}
] |
10-Q | 0000766704-23-000017 | 20230503073226 | 20230331 | WELLTOWER INC. | For the majority of our Seniors Housing Operating segment, revenue from resident fees and services is predominantly service-based, and as such, resident agreements are accounted for under ASC 606, "Revenue from Contracts with Customers." Within that reportable segment, we also recognize revenue from residential seniors apartment leases in accordance with ASC 842. The amount of revenue related to these leases was $108,915,000 and $94,827,000 for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 428,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 417,
"start_date_for_period": "2023-01-01",
"value": 108915000
},
{
"currency_/_unit": "USD",
"end_character": 444,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 434,
"start_date_for_period": "2022-01-01",
"value": 94827000
}
] |
10-Q | 0000040729-23-000012 | 20230502172228 | 20230331 | Ally Financial Inc. | We recognized operating lease revenue of $402 million for the three months ended, March 31, 2023, and $403 million for the three months ended March 31, 2022. Depreciation expense on operating lease assets includes net remarketing gains recognized on the sale of operating lease assets. The following table summarizes the components of depreciation expense on operating lease assets. | [
{
"currency_/_unit": "USD",
"end_character": 45,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 42,
"start_date_for_period": "2023-01-01",
"value": 402000000
},
{
"currency_/_unit": "USD",
"end_character": 106,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 103,
"start_date_for_period": "2022-01-01",
"value": 403000000
}
] |
10-Q | 0000850429-23-000010 | 20230508081811 | 20230331 | TREDEGAR CORP | The Company’s facilities in Pottsville, PA (“PV”) and Guangzhou, China (“GZ”) have a tolling arrangement whereby certain surface protection films are manufactured in GZ for a fee with raw materials supplied from PV that are then shipped by GZ directly to customers principally in the Asian market, but paid by customers directly to PV. Amounts associated with this intercompany tolling arrangement are reported in the table above as export sales from the U.S. to Asia, and include net sales of $3.4 million and $6.5 million in the first three months of 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 499,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 496,
"start_date_for_period": "2023-01-01",
"value": 3400000
},
{
"currency_/_unit": "USD",
"end_character": 516,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 513,
"start_date_for_period": "2022-01-01",
"value": 6500000
}
] |
10-Q | 0001493152-23-017405 | 20230515162232 | 20230331 | Power REIT | The
Trust has elected to be treated for tax purposes as a REIT, which means that it is exempt from U.S. federal income tax if a sufficient
portion of its annual income is distributed to its shareholders, and if certain other requirements are met. In order for the Trust to
maintain its REIT qualification, at least 90% of its ordinary taxable annual income must be distributed to shareholders. As of December
31, 2021, the last tax return completed to date, the Trust has a net operating loss of $24.8 million, which may reduce or eliminate this
requirement. | [
{
"currency_/_unit": "pure",
"end_character": 317,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 315,
"start_date_for_period": "2023-01-01",
"value": 0.9
},
{
"currency_/_unit": "USD",
"end_character": 501,
"end_date_for_period": "2021-12-31",
"label": "ebit",
"start_character": 497,
"start_date_for_period": "2021-01-01",
"value": 24800000
}
] |
10-Q | 0000877860-23-000066 | 20230509160926 | 20230331 | NATIONAL HEALTH INVESTORS INC | Rent concessions granted for the three months ended March 31, 2022 totaled approximately $7.8 million, of which Bickford accounted for approximately $5.5 million. | [
{
"currency_/_unit": "USD",
"end_character": 93,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 90,
"start_date_for_period": "2022-01-01",
"value": 7800000
},
{
"currency_/_unit": "USD",
"end_character": 153,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 150,
"start_date_for_period": "2022-01-01",
"value": 5500000
}
] |
10-Q | 0001805284-23-000033 | 20230510164345 | 20230331 | Rocket Companies, Inc. | The Company had an income tax benefit of $4,504 on Loss before income taxes of $415,987 for the three months ended March 31, 2023. The Company had income tax expense of $25,849 on Income before income taxes of $1,062,457 for the three months ended March 31, 2022. | [
{
"currency_/_unit": "USD",
"end_character": 47,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 42,
"start_date_for_period": "2023-01-01",
"value": -4504000
},
{
"currency_/_unit": "USD",
"end_character": 87,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 80,
"start_date_for_period": "2023-01-01",
"value": -415987000
},
{
"currency_/_unit": "USD",
"end_character": 176,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 170,
"start_date_for_period": "2022-01-01",
"value": 25849000
},
{
"currency_/_unit": "USD",
"end_character": 220,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 211,
"start_date_for_period": "2022-01-01",
"value": 1062457000
}
] |
10-Q | 0001046311-23-000021 | 20230509135520 | 20230331 | CHOICE HOTELS INTERNATIONAL INC /DE | As presented in Note 11, the Corporate & Other segment revenue amounts represent $26.1 million and $14.3 million for the three months ended March 31, 2023 and 2022, and are included in the Over time column of Other revenue and the Owned hotels revenue row. The remaining revenues relate to the Hotel Franchising & Management reportable segment. | [
{
"currency_/_unit": "USD",
"end_character": 86,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 82,
"start_date_for_period": "2023-01-01",
"value": 26100000
},
{
"currency_/_unit": "USD",
"end_character": 104,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 100,
"start_date_for_period": "2022-01-01",
"value": 14300000
}
] |
10-Q | 0000029644-23-000055 | 20230605140321 | 20230430 | DONALDSON Co INC | Earnings before income taxes for the Life Sciences segment for the nine months ended April 30, 2023 were $17.3 million, or 9.5% of net sales, a decrease from 24.2% of net sales for the nine months ended April 30, 2022. The decrease was driven by lower disk drive sales volumes causing a decline in profitability and the expected initial negative earnings impact from the recent acquisitions. | [
{
"currency_/_unit": "USD",
"end_character": 110,
"end_date_for_period": "2023-04-30",
"label": "earnings",
"start_character": 106,
"start_date_for_period": "2022-08-01",
"value": 17300000
}
] |
10-Q | 0001493152-23-018686 | 20230523131051 | 20230331 | Ayala Pharmaceuticals, Inc. | Revenue
associated with the research and development services in the amount of approximately $4 thousand was recognized in the three months ended
March 31, 2023. | [
{
"currency_/_unit": "USD",
"end_character": 95,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 94,
"start_date_for_period": "2023-01-01",
"value": 4000
}
] |
10-Q | 0001493152-23-018686 | 20230523131051 | 20230331 | Ayala Pharmaceuticals, Inc. | Revenue
associated with the research and development services in the amount of approximately $0.5 million was recognized in the three months
ended March 31, 2022. | [
{
"currency_/_unit": "USD",
"end_character": 97,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 94,
"start_date_for_period": "2022-01-01",
"value": 500000
}
] |
10-Q | 0001795250-23-000014 | 20230510164730 | 20230331 | Sphere Entertainment Co. | This adjustment represents the non-cash portion of operating lease revenue related to the Company’s Arena License Agreements with MSG Sports. Pursuant to GAAP, recognition of operating lease revenue is recorded on a straight-line basis over the term of the agreement based upon the value of total future payments under the arrangement. As a result, operating lease revenue is comprised of a contractual cash component plus or minus a non-cash component for each period presented. Operating income on a GAAP basis includes lease income of (i) $19,014 and $39,234 of revenue collected in cash for the three and nine months ended March 31, 2023, respectively, and $17,543 and $34,836 of revenue collected in cash for the three and nine months ended March 31, 2022, respectively, and (ii) a non-cash portion of $12,149 and $25,078 for the three and nine months ended March 31, 2023, respectively, and $12,073 and $23,962for the three and nine months ended March 31, 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 549,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 543,
"start_date_for_period": "2023-01-01",
"value": 19014000
},
{
"currency_/_unit": "USD",
"end_character": 561,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 555,
"start_date_for_period": "2022-07-01",
"value": 39234000
},
{
"currency_/_unit": "USD",
"end_character": 668,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 662,
"start_date_for_period": "2022-01-01",
"value": 17543000
},
{
"currency_/_unit": "USD",
"end_character": 680,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 674,
"start_date_for_period": "2021-07-01",
"value": 34836000
},
{
"currency_/_unit": "USD",
"end_character": 814,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 808,
"start_date_for_period": "2022-01-01",
"value": 12149000
},
{
"currency_/_unit": "USD",
"end_character": 826,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 820,
"start_date_for_period": "2021-07-01",
"value": 25078000
},
{
"currency_/_unit": "USD",
"end_character": 904,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 898,
"start_date_for_period": "2023-01-01",
"value": 12073000
},
{
"currency_/_unit": "USD",
"end_character": 916,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 910,
"start_date_for_period": "2022-07-01",
"value": 23962000
}
] |
10-Q | 0001493152-23-017254 | 20230515160101 | 20230331 | Yunhong CTI Ltd. | The
Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”)
applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.
The Company has a cumulative net loss from inception to March 31, 2023 of approximately $23 million. The accompanying financial statements
for the three months ended March 31, 2023 have been prepared assuming the Company will continue as a going concern. The Company’s
cash resources from operations may be insufficient to meet its anticipated needs during the next twelve months. If the Company does not
execute its plan, it may require additional financing to fund its future planned operations. | [
{
"currency_/_unit": "USD",
"end_character": 341,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 339,
"start_date_for_period": "2023-03-30",
"value": 23000000
}
] |
10-Q | 0001703644-23-000073 | 20230509165702 | 20230331 | Granite Point Mortgage Trust Inc. | For the three months ended March 31, 2023, and 2022, excluded from the calculation of diluted earnings per share is the effect of adding back $2.3 million and $4.5 million, respectively, of interest expense and 6,591,765 and 14,065,946, respectively, of weighted average common share equivalents related to the assumed conversion of the Company’s convertible senior notes, as their inclusion would be antidilutive. | [
{
"currency_/_unit": "USD",
"end_character": 146,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 143,
"start_date_for_period": "2023-01-01",
"value": 2300000
},
{
"currency_/_unit": "USD",
"end_character": 163,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 160,
"start_date_for_period": "2022-01-01",
"value": 4500000
},
{
"currency_/_unit": "shares",
"end_character": 220,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 211,
"start_date_for_period": "2023-01-01",
"value": 6591765
},
{
"currency_/_unit": "shares",
"end_character": 235,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 225,
"start_date_for_period": "2022-01-01",
"value": 14065946
}
] |
10-Q | 0001703644-23-000073 | 20230509165702 | 20230331 | Granite Point Mortgage Trust Inc. | The computation of diluted earnings per share is also based on the incremental shares that would be outstanding assuming the settlement of RSUs. The number of incremental shares is calculated by applying the treasury stock method. For the three months ended March 31, 2022, an additional 104,446 weighted-average unvested RSUs were included in the dilutive earnings per share denominator. For the three months ended March 31, 2023, 1,219,646 weighted-average unvested RSUs were excluded in the dilutive earnings per share denominator, as their inclusion would be antidilutive. | [
{
"currency_/_unit": "shares",
"end_character": 295,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 288,
"start_date_for_period": "2022-01-01",
"value": 104446
},
{
"currency_/_unit": "shares",
"end_character": 441,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 432,
"start_date_for_period": "2023-01-01",
"value": 1219646
}
] |
10-Q | 0001829126-23-003233 | 20230510163159 | 20230331 | Airspan Networks Holdings Inc. | There
was no revenue recognized at a point in time for NRE services for the three months ended March 31, 2023 or for the three months
ended March 31, 2022. For services performed on a customer’s owned asset, since the customer controls the asset being enhanced,
revenue is recognized over time as services are rendered. Revenue recognized over time for NRE services using a cost-based input method
amounted to $0.5 million and $1.2 million for the three months ended March 31, 2023 and 2022, respectively. The Company is allowed
to bill for services performed under the contract in the event the contract is terminated. | [
{
"currency_/_unit": "USD",
"end_character": 414,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 411,
"start_date_for_period": "2023-01-01",
"value": 500000
},
{
"currency_/_unit": "USD",
"end_character": 431,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 428,
"start_date_for_period": "2022-01-01",
"value": 1200000
}
] |
10-Q | 0001493152-23-017256 | 20230515160136 | 20230331 | Rennova Health, Inc. | At
March 31, 2023, the Company had a working capital deficit and a stockholders’ deficit of $42.2 million and $28.3 million, respectively.
While we generated $0.8 million of income in the three months ended March 31, 2023, we incurred losses of $2.3 million and $3.3 million in the three months ended March 31, 2022 and the year ended December 31, 2022,
respectively. As of the date of this report, our cash is deficient and payments for our operations in the ordinary course are not being
made. The losses in prior periods and other related factors, including past due accounts payable and payroll taxes, as well as payment
defaults under the terms of outstanding notes payable and debentures, raise substantial doubt about the Company’s ability to continue
as a going concern for 12 months from the filing date of this report. | [
{
"currency_/_unit": "USD",
"end_character": 97,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 93,
"start_date_for_period": "2023-03-31",
"value": 42200000
},
{
"currency_/_unit": "USD",
"end_character": 115,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 111,
"start_date_for_period": "2023-03-31",
"value": -28300000
},
{
"currency_/_unit": "USD",
"end_character": 162,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 159,
"start_date_for_period": "2023-01-01",
"value": 800000
},
{
"currency_/_unit": "USD",
"end_character": 249,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 246,
"start_date_for_period": "2022-01-01",
"value": -2300000
},
{
"currency_/_unit": "USD",
"end_character": 266,
"end_date_for_period": "2022-12-31",
"label": "earnings",
"start_character": 263,
"start_date_for_period": "2022-01-01",
"value": -3300000
}
] |
10-Q | 0001600626-23-000092 | 20230509161510 | 20230331 | Peakstone Realty Trust | The Company recognized $58.3 million and $97.2 million of lease income related to operating lease payments for the three months ended March 31, 2023 and March 31, 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 28,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 24,
"start_date_for_period": "2023-01-01",
"value": 58300000
},
{
"currency_/_unit": "USD",
"end_character": 46,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 42,
"start_date_for_period": "2022-01-01",
"value": 97200000
}
] |
10-Q | 0001056358-23-000038 | 20230511210435 | 20230331 | MANNATECH INC | For the three months ended March 31, 2022, there were 1.95 million weighted-average common shares outstanding used for the basic EPS calculation. For the three months ended March 31, 2022, approximately 0.12 million shares subject to options were included in the calculation resulting in | [
{
"currency_/_unit": "shares",
"end_character": 58,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 54,
"start_date_for_period": "2022-01-01",
"value": 1950000
},
{
"currency_/_unit": "shares",
"end_character": 207,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 203,
"start_date_for_period": "2022-01-01",
"value": 120000
}
] |
10-Q | 0001493152-23-018445 | 20230522061251 | 20230331 | Newpoint Financial Corp | The
accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization
of assets and the satisfaction of liabilities in the normal course of business. The Company has no revenue and has generated net losses
of $169,605 and $172,684 during the quarters ended March 31, 2023 and March 31, 2022, respectively. The Company has an accumulated deficit
of $2,041,643 and $1,872,038 as of March 31, 2023 and December 31, 2022, and has experienced negative cash flows from operations. These
circumstances raise doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do
not include any adjustments that might result from the outcome of this uncertainty. | [
{
"currency_/_unit": "USD",
"end_character": 294,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 287,
"start_date_for_period": "2023-01-01",
"value": -169605
},
{
"currency_/_unit": "USD",
"end_character": 307,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 300,
"start_date_for_period": "2022-01-01",
"value": -172684
}
] |
10-Q | 0001061630-23-000027 | 20230426064959 | 20230331 | BLACKSTONE MORTGAGE TRUST, INC. | For the three months ended March 31, 2023, represents 8.3 million of weighted average shares, using the if-converted method, related to our March 2022 Convertible Notes. For the three months ended March 31, 2022, represents 8.3 million and 6.1 million of weighted-average shares, using the if-converted method, related to our March 2022 and March 2018 Convertible Notes, respectively. Our March 2018 Convertible Notes were repaid during the three months ended March 31, 2023. Refer to Note 11 for additional discussion on our Convertible Notes. | [
{
"currency_/_unit": "shares",
"end_character": 57,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 54,
"start_date_for_period": "2023-01-01",
"value": 8300000.000000001
},
{
"currency_/_unit": "shares",
"end_character": 227,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 224,
"start_date_for_period": "2023-01-01",
"value": 8300000.000000001
},
{
"currency_/_unit": "shares",
"end_character": 243,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 240,
"start_date_for_period": "2022-01-01",
"value": 6100000
}
] |
10-Q | 0001283140-23-000035 | 20230505150037 | 20230331 | HOLLY ENERGY PARTNERS LP | Revenues received from HF Sinclair were $116.9 million and $92.3 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 46,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 41,
"start_date_for_period": "2023-01-01",
"value": 116900000
},
{
"currency_/_unit": "USD",
"end_character": 64,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 60,
"start_date_for_period": "2022-01-01",
"value": 92300000
}
] |
10-Q | 0000068622-23-000008 | 20230503160849 | 20230331 | QWEST CORP | For the three months ended March 31, 2023 and 2022, our gross rental income was $80 million and $88 million, respectively, which represents approximately 5% of our operating revenue for both periods. | [
{
"currency_/_unit": "USD",
"end_character": 83,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 81,
"start_date_for_period": "2023-01-01",
"value": 80000000
},
{
"currency_/_unit": "USD",
"end_character": 99,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 97,
"start_date_for_period": "2022-01-01",
"value": 88000000
}
] |
10-Q | 0001860782-23-000076 | 20230510160354 | 20230331 | 2seventy bio, Inc. | , the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. The Company has incurred losses and has experienced negative operating cash flows for all historical periods presented. During the three months ended March 31, 2023, the Company incurred a net loss of $47.0 million and used $49.1 million of cash in operations. The Company expects to continue to generate operating losses and negative operating cash flows for the next few years. The Company's continued operations are dependent on its ability to raise additional funding and generate operating cash flows from the commercialization of its product candidates, if approved. | [
{
"currency_/_unit": "USD",
"end_character": 474,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 470,
"start_date_for_period": "2023-01-01",
"value": -47000000
},
{
"currency_/_unit": "USD",
"end_character": 497,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 493,
"start_date_for_period": "2023-01-01",
"value": -49100000
}
] |
10-Q | 0001493152-23-016832 | 20230515061153 | 20230331 | GENELUX CORP | The
accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement
of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, the Company incurred
a net loss of $10,364 | [
{
"currency_/_unit": "USD",
"end_character": 309,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 303,
"start_date_for_period": "2023-01-01",
"value": -10364000
}
] |
10-Q | 0001136352-23-000006 | 20230504160912 | 20230331 | Crestwood Equity Partners LP | Includes (i) $59.0 million during the three months ended March 31, 2022 primarily related to the sale of crude oil and NGLs to a subsidiary of Chord; (ii) $36.6 million during the three months ended March 31, 2022 primarily related to gathering and processing services provided to a subsidiary of Chord; (iii) $1.6 million during the three months ended March 31, 2022 related to the sale of NGLs to a subsidiary of Crestwood Permian; and (iv) $0.5 million during the three months ended March 31, 2022 related to compressor leases with a subsidiary of Crestwood Permian. | [
{
"currency_/_unit": "USD",
"end_character": 18,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 14,
"start_date_for_period": "2022-01-01",
"value": 59000000
},
{
"currency_/_unit": "USD",
"end_character": 160,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 156,
"start_date_for_period": "2022-01-01",
"value": 36600000
},
{
"currency_/_unit": "USD",
"end_character": 314,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 311,
"start_date_for_period": "2022-01-01",
"value": 1600000
},
{
"currency_/_unit": "USD",
"end_character": 447,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 444,
"start_date_for_period": "2022-01-01",
"value": 500000
}
] |
10-Q | 0000899051-23-000037 | 20230503161826 | 20230331 | ALLSTATE CORP | The results of operations of the Reciprocal Exchanges are included in the Company’s Allstate Protection segment and generated $57 million of earned premiums for the three months ended March 31, 2023 compared to $42 million for the three months ended March 31, 2022. | [
{
"currency_/_unit": "USD",
"end_character": 129,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 127,
"start_date_for_period": "2023-01-01",
"value": 57000000
},
{
"currency_/_unit": "USD",
"end_character": 214,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 212,
"start_date_for_period": "2022-01-01",
"value": 42000000
}
] |
10-Q | 0000832428-23-000019 | 20230505123709 | 20230331 | E.W. SCRIPPS Co | The dilutive effects of performance-based stock awards are included in the computation of diluted earnings per share to the extent the related performance criteria are met through the respective balance sheet reporting date. As of March 31, 2023, potential dilutive securities representing 420,000 shares were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future | [
{
"currency_/_unit": "shares",
"end_character": 297,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 290,
"start_date_for_period": "2023-01-01",
"value": 420000
}
] |
10-Q | 0001378453-23-000010 | 20230427171705 | 20230331 | TravelCenters of America Inc. /MD/ | During 2022, we acquired the operating assets related to two travel centers we previously leased to franchisees. Rent revenues from these operating leases totaled $595 for the three months ended March 31, 2022. See above for information regarding certain travel centers that we lease from SVC in which we sublease a portion of the travel centers to third parties to operate other retail operations. We also lease portions of owned properties to third parties to operate other retail operations. | [
{
"currency_/_unit": "ta:travel_center",
"end_character": 60,
"end_date_for_period": "2022-12-31",
"label": "XBRL-OOS",
"start_character": 57,
"start_date_for_period": "2022-12-31",
"value": 2
},
{
"currency_/_unit": "USD",
"end_character": 167,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 164,
"start_date_for_period": "2022-01-01",
"value": 595000
}
] |
10-Q | 0001574197-23-000041 | 20230421182505 | 20230331 | Five Point Holdings, LLC | Other than a small income tax provision attributed to one of the Company’s consolidated subsidiary corporations, during the three months ended March 31, 2023 and 2022, the Company recorded no provision or benefit for income taxes (after application of an increase in the Company’s valuation allowance) on pre-tax loss of $9.7 million and $36.8 million, respectively. The effective tax rates for the three months ended March 31, 2023 and 2022, differ from the 21% federal statutory rate and applicable state statutory rates primarily due to the Company’s valuation allowance on its book losses, disallowance of executive compensation expenses not deductible for tax, and to the pre-tax portion of income and losses that are passed through to the other partners of the Operating Company and the San Francisco Venture. | [
{
"currency_/_unit": "USD",
"end_character": 325,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 322,
"start_date_for_period": "2023-01-01",
"value": -9700000
},
{
"currency_/_unit": "USD",
"end_character": 343,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 339,
"start_date_for_period": "2022-01-01",
"value": -36800000
}
] |
10-Q | 0001801777-23-000037 | 20230511161051 | 20230331 | Applied Molecular Transport Inc. | The Company has incurred net losses in each reporting period since inception, including net losses of $27.9 million and $42.6 million for the three months ended March 31, 2023 and 2022, respectively, and the Company’s accumulated deficit at March 31, 2023 was $393.9 million. The Company’s current operating plan, which is subject to change based on the ongoing strategic review, indicates it will continue to incur losses from operations and generate negative cash flows from operating activities, given the Company does not generate any revenue from product sales or otherwise. | [
{
"currency_/_unit": "USD",
"end_character": 107,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 103,
"start_date_for_period": "2023-01-01",
"value": -27900000
},
{
"currency_/_unit": "USD",
"end_character": 125,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 121,
"start_date_for_period": "2022-01-01",
"value": -42600000
},
{
"currency_/_unit": "USD",
"end_character": 266,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 261,
"start_date_for_period": "2023-03-31",
"value": -393900000
}
] |
10-Q | 0001493152-23-018583 | 20230522171549 | 20230331 | Verb Technology Company, Inc. | The
accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets
and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial
statements, during the three months ended March 31, 2023, the Company incurred a net loss of $5,514 and used cash in operations of $2,918.
These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date
of the financial statements being issued. | [
{
"currency_/_unit": "USD",
"end_character": 380,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 375,
"start_date_for_period": "2023-01-01",
"value": -5514000
},
{
"currency_/_unit": "USD",
"end_character": 418,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 413,
"start_date_for_period": "2023-01-01",
"value": -2918000
}
] |
10-Q | 0001627282-23-000012 | 20230622174534 | 20230331 | CaliberCos Inc. | Consolidated funds – other revenue primarily consists of rental revenue of $1.0 million and $1.3 million for the three months ended March 31, 2023 and 2022, respectively. Rental revenue includes the revenues generated primarily by the rental operations of the residential (multi-family and single-family) and commercial properties of our consolidated funds. | [
{
"currency_/_unit": "USD",
"end_character": 79,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 76,
"start_date_for_period": "2023-01-01",
"value": 1000000
},
{
"currency_/_unit": "USD",
"end_character": 96,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 93,
"start_date_for_period": "2022-01-01",
"value": 1300000
}
] |
10-Q | 0000099780-23-000044 | 20230502142702 | 20230331 | TRINITY INDUSTRIES INC | Our Leasing Group enters into railcar operating leases with third parties with terms generally ranging between one year and ten years. The majority of our fleet operates on leases that earn fixed monthly lease payments. Generally, lease payments are due at the beginning of the applicable month. A portion of our fleet operates on per diem leases that earn usage-based variable lease payments. Some of our leases include options to extend the leases for up to five years, and a small percentage of our leases include early termination options with certain notice requirements and early termination penalties. As of March 31, 2023, non-Leasing Group operating leases were not significant, and we had no direct finance leases. | [
{
"currency_/_unit": "USD",
"end_character": 558,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 556,
"start_date_for_period": "2023-01-01",
"value": 0
}
] |
10-Q | 0001355848-23-000015 | 20230522090120 | 20230331 | Genius Brands International, Inc. | During the three months ended March 31, 2023, SLU generated $0.1 million in net income. The Company's net investment as of March 31, 2023 of $0.8 million, remained the same as compared to December 31, 2022. There were no changes in facts and circumstances that occurred during the three months ended March 31, 2023 that would result in a re-evaluation of the VIE assessment. | [
{
"currency_/_unit": "USD",
"end_character": 64,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 61,
"start_date_for_period": "2023-01-01",
"value": 100000
}
] |
10-Q | 0000028823-23-000117 | 20230530073953 | 20230331 | DIEBOLD NIXDORF, Inc | The Company has a Russian distribution subsidiary that generated approximately $45.0 in revenue and $5.0 in operating profit during the year ended December 31, 2021. Due to the economic sanctions levied on and economic conditions in Russia, the Company is making progress towards liquidating the distribution subsidiary. | [
{
"currency_/_unit": "USD",
"end_character": 84,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 80,
"start_date_for_period": "2022-01-01",
"value": 45000000
},
{
"currency_/_unit": "USD",
"end_character": 104,
"end_date_for_period": "2022-03-31",
"label": "ebit",
"start_character": 101,
"start_date_for_period": "2022-01-01",
"value": 5000000
}
] |
10-Q | 0000028823-23-000117 | 20230530073953 | 20230331 | DIEBOLD NIXDORF, Inc | Additionally, the Company has distribution partners in Russia, Ukraine and Belarus that generated approximately $35.0 in revenue and $5.0 in gross profit during the year ended December 31, 2021. Due to the Russian incursion into Ukraine and the related economic sanctions, the prospect of re-establishing revenue from these relationships is currently uncertain. | [
{
"currency_/_unit": "USD",
"end_character": 117,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 113,
"start_date_for_period": "2022-01-01",
"value": 35000000
},
{
"currency_/_unit": "USD",
"end_character": 137,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 134,
"start_date_for_period": "2022-01-01",
"value": 5000000
}
] |
10-Q | 0000937834-23-000014 | 20230509164753 | 20230331 | METROPOLITAN LIFE INSURANCE CO | The Company has entered into various agreements with affiliates for services necessary to conduct its activities. Typical services provided under these agreements include personnel, policy administrative functions and distribution services. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual cost incurred by the Company and/or its affiliates. Expenses and fees incurred with affiliates related to these agreements, recorded in other expenses, were $715 million and $636 million for the three months ended March 31, 2023 and 2022, respectively. Total revenues received from affiliates related to these agreements were $14 million and $12 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 542,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 539,
"start_date_for_period": "2023-01-01",
"value": 715000000
},
{
"currency_/_unit": "USD",
"end_character": 559,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 556,
"start_date_for_period": "2022-01-01",
"value": 636000000
},
{
"currency_/_unit": "USD",
"end_character": 710,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 708,
"start_date_for_period": "2023-01-01",
"value": 14000000
},
{
"currency_/_unit": "USD",
"end_character": 726,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 724,
"start_date_for_period": "2022-01-01",
"value": 12000000
}
] |
10-Q | 0001007587-23-000004 | 20230505140929 | 20230331 | KVH INDUSTRIES INC \DE\ | Lease revenue recognized was $138 for the three months ended March 31, 2023 in service sales in the consolidated statements of operations. | [
{
"currency_/_unit": "USD",
"end_character": 33,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 30,
"start_date_for_period": "2023-01-01",
"value": 138000
}
] |
10-Q | 0001689548-23-000086 | 20230511073702 | 20230331 | Praxis Precision Medicines, Inc. | The Company has incurred recurring losses since its inception, including a net loss of $37.5 million for the three months ended March 31, 2023. In addition, as of March 31, 2023, the Company had an accumulated deficit of $568.1 million. The Company expects to continue to generate operating losses for the foreseeable future. | [
{
"currency_/_unit": "USD",
"end_character": 92,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 88,
"start_date_for_period": "2023-01-01",
"value": -37500000
},
{
"currency_/_unit": "USD",
"end_character": 227,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 222,
"start_date_for_period": "2023-03-31",
"value": -568100000
}
] |
10-Q | 0000912752-23-000025 | 20230510151043 | 20230331 | SINCLAIR BROADCAST GROUP INC | As we consolidate the licensees as VIEs, the amounts we earn or pay under the arrangements are eliminated in consolidation and the gross revenues of the stations are reported in our consolidated statements of operations. Our consolidated revenues include $36 million for the three months ended March 31, 2023 and $34 million for the three months ended March 31, 2022 related to the Cunningham Stations. | [
{
"currency_/_unit": "USD",
"end_character": 258,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 256,
"start_date_for_period": "2023-01-01",
"value": 36000000
},
{
"currency_/_unit": "USD",
"end_character": 316,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 314,
"start_date_for_period": "2022-01-01",
"value": 34000000
}
] |
10-Q | 0000050863-23-000028 | 20230427182504 | 20230401 | INTEL CORP | Revenue was $118 million, down $38 million from Q1 2022 driven by lower sales of multi-beam mask writer tools. We had an operating loss of $140 million, compared to an operating loss of $23 million in Q1 2022, primarily due to increased factory startup costs. | [
{
"currency_/_unit": "USD",
"end_character": 16,
"end_date_for_period": "2023-04-01",
"label": "XBRL-OOS",
"start_character": 13,
"start_date_for_period": "2023-01-01",
"value": 118000000
},
{
"currency_/_unit": "USD",
"end_character": 143,
"end_date_for_period": "2023-04-01",
"label": "ebit",
"start_character": 140,
"start_date_for_period": "2023-01-01",
"value": -140000000
}
] |
10-Q | 0001438133-23-000067 | 20230503161227 | 20230331 | TANDEM DIABETES CARE INC | For the three months ended March 31, 2023, the Company recognized income tax expense of $0.3 million on a pre-tax loss of $123.6 million. Income tax expense for the three months ended March 31, 2023 was primarily attributable to state and foreign income tax expense as a result of current taxable income in certain jurisdictions. | [
{
"currency_/_unit": "USD",
"end_character": 92,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 89,
"start_date_for_period": "2023-01-01",
"value": 300000
},
{
"currency_/_unit": "USD",
"end_character": 128,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 123,
"start_date_for_period": "2023-01-01",
"value": -123600000
}
] |
10-Q | 0001438133-23-000067 | 20230503161227 | 20230331 | TANDEM DIABETES CARE INC | For the three months ended March 31, 2022, the Company recognized an income tax benefit of $1.7 million on a pre-tax loss of $16.4 million. The income tax benefit for the three months ended March 31, 2022, was primarily attributable to the Company’s pre-tax loss position, offset by state and foreign income tax expense as a result of current taxable income in certain jurisdictions. | [
{
"currency_/_unit": "USD",
"end_character": 95,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 92,
"start_date_for_period": "2022-01-01",
"value": -1700000
},
{
"currency_/_unit": "USD",
"end_character": 130,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 126,
"start_date_for_period": "2022-01-01",
"value": -16399999.999999998
}
] |
10-Q | 0001434728-23-000152 | 20230502215853 | 20230331 | Global Water Resources, Inc. | During the three months ended March 31, 2023, tax expense of $0.9 million was recorded on pre-tax income of $3.3 million for the three months ended March 31, 2023, and tax expense of $0.3 million was recorded on pre-tax income of $1.2 million for the three months ended March 31, 2022. | [
{
"currency_/_unit": "USD",
"end_character": 65,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 62,
"start_date_for_period": "2023-01-01",
"value": 900000
},
{
"currency_/_unit": "USD",
"end_character": 112,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 109,
"start_date_for_period": "2023-01-01",
"value": 3300000
},
{
"currency_/_unit": "USD",
"end_character": 187,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 184,
"start_date_for_period": "2022-01-01",
"value": 300000
},
{
"currency_/_unit": "USD",
"end_character": 234,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 231,
"start_date_for_period": "2022-01-01",
"value": 1200000
}
] |
10-Q | 0001632970-23-000058 | 20230515131842 | 20230331 | American Healthcare REIT, Inc. | Basic earnings (loss) per share for all periods presented are computed by dividing net income (loss) applicable to common stock by the weighted average number of shares of our common stock outstanding during the period. Net income (loss) applicable to common stock is calculated as net income (loss) attributable to controlling interest less distributions allocated to participating securities of $926,000 and $1,490,000 for the three months ended March 31, 2023 and 2022, respectively. Diluted earnings (loss) per share are computed based on the weighted average number of shares of our common stock and all potentially dilutive securities, if any. TBUs, nonvested shares of our RSAs and limited partnership units of our operating partnership are participating securities and give rise to potentially dilutive shares of our common stock. | [
{
"currency_/_unit": "USD",
"end_character": 405,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 398,
"start_date_for_period": "2023-01-01",
"value": 926000
},
{
"currency_/_unit": "USD",
"end_character": 420,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 411,
"start_date_for_period": "2022-01-01",
"value": 1490000
}
] |
10-Q | 0001101680-23-000043 | 20230509160326 | 20230331 | DZS INC. | Income tax expense for the three months ended March 31, 2023 was approximately $1.8 million on pre-tax loss of $15.3 million. Income tax benefit for the three months ended March 31, 2022 was approximately $1.3 million on pre-tax loss of $4.4 million. | [
{
"currency_/_unit": "USD",
"end_character": 83,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 80,
"start_date_for_period": "2023-01-01",
"value": 1800000
},
{
"currency_/_unit": "USD",
"end_character": 116,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 112,
"start_date_for_period": "2023-01-01",
"value": -15300000
},
{
"currency_/_unit": "USD",
"end_character": 209,
"end_date_for_period": "2022-03-31",
"label": "XBRL-OOS",
"start_character": 206,
"start_date_for_period": "2022-01-01",
"value": -1300000
},
{
"currency_/_unit": "USD",
"end_character": 241,
"end_date_for_period": "2022-03-31",
"label": "earnings",
"start_character": 238,
"start_date_for_period": "2022-01-01",
"value": -4400000
}
] |
10-Q | 0000777917-23-000026 | 20230511163833 | 20230331 | PRUCO LIFE INSURANCE CO | The Company pays commissions and certain other fees to Prudential Annuities Distributors, Inc. (“PAD”) in consideration for PAD’s marketing and underwriting of the Company’s annuity products. Commissions and fees are paid by PAD to broker-dealers who sell the Company’s annuity products. Commissions and fees paid by the Company to PAD were $140 million and $170 million for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 345,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 342,
"start_date_for_period": "2023-01-01",
"value": 140000000
},
{
"currency_/_unit": "USD",
"end_character": 362,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 359,
"start_date_for_period": "2022-01-01",
"value": 170000000
}
] |
10-Q | 0001628280-23-017583 | 20230511162412 | 20230331 | VYNE Therapeutics Inc. | Since inception, the Company has funded operations primarily through private and public placements of its equity, debt and warrants and through fees, cost reimbursements and payments received from its licensees. The Company commenced generating product revenues related to sales of AMZEEQ and ZILXI in January 2020 and October 2020, respectively. AMZEEQ and ZILXI were sold as part of the sale of the MST Franchise on January 12, 2022 and, as such, the Company no longer generates revenue from the sale of these products. The Company has incurred losses and experienced negative operating cash flows since its inception and anticipates that it will continue to incur losses until such a time when its product candidates, if approved, are commercially successful, if at all. The Company will not generate any revenue from any current or future product candidates unless and until it obtains regulatory approval and commercializes such products. For the three months ended March 31, 2023, the Company incurred a net loss of $5.6 million and used $5.5 million of cash in operations. | [
{
"currency_/_unit": "USD",
"end_character": 1026,
"end_date_for_period": "2023-03-31",
"label": "earnings",
"start_character": 1023,
"start_date_for_period": "2023-01-01",
"value": -5600000
},
{
"currency_/_unit": "USD",
"end_character": 1048,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 1045,
"start_date_for_period": "2023-01-01",
"value": -5500000
}
] |
10-Q | 0001823945-23-000029 | 20230504163926 | 20230331 | BLUE OWL CAPITAL INC. | Included in the weighted-average Class A Shares outstanding are RSUs that have vested but have not been settled in Class A Shares. These RSUs do not participate in dividends until settled in Class A Shares. These vested RSUs totaled 10,736,476 for the three months ended March 31, 2023, and 10,928,095 for the three months ended March 31, 2022. | [
{
"currency_/_unit": "shares",
"end_character": 243,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 233,
"start_date_for_period": "2023-01-01",
"value": 10736476
},
{
"currency_/_unit": "shares",
"end_character": 301,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 291,
"start_date_for_period": "2022-01-01",
"value": 10928095
}
] |
10-Q | 0001630805-23-000010 | 20230510070557 | 20230331 | Babcock & Wilcox Enterprises, Inc. | If the Company had net income in the three months ended March 31, 2023 and March 31, 2022, diluted shares would include an additional 0.4 million and 0.9 million shares, respectively. | [
{
"currency_/_unit": "shares",
"end_character": 137,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 134,
"start_date_for_period": "2023-01-01",
"value": 400000
},
{
"currency_/_unit": "shares",
"end_character": 153,
"end_date_for_period": "2022-03-31",
"label": "eps",
"start_character": 150,
"start_date_for_period": "2022-01-01",
"value": 900000
}
] |
10-Q | 0001446371-23-000021 | 20230515141641 | 20230331 | Strategic Realty Trust, Inc. | The Company’s condensed consolidated statements of operations and comprehensive income include a net operating loss of approximately $23 thousand for the three months ended March 31, 2023 and a net operating gain of approximately $208 thousand for the three months ended March 31, 2022, related to the Sunset & Gardner Joint Venture Property. | [
{
"currency_/_unit": "USD",
"end_character": 136,
"end_date_for_period": "2023-03-31",
"label": "ebit",
"start_character": 134,
"start_date_for_period": "2023-01-01",
"value": -23000
},
{
"currency_/_unit": "USD",
"end_character": 234,
"end_date_for_period": "2022-03-31",
"label": "ebit",
"start_character": 231,
"start_date_for_period": "2022-01-01",
"value": 208000
}
] |
10-Q | 0001446371-23-000021 | 20230515141641 | 20230331 | Strategic Realty Trust, Inc. | The Company’s condensed consolidated statements of operations include net operating losses of approximately $70 thousand and $379 thousand for the three months ended March 31, 2023 and 2022, respectively, related to the Wilshire Joint Venture Property. | [
{
"currency_/_unit": "USD",
"end_character": 111,
"end_date_for_period": "2023-03-31",
"label": "ebit",
"start_character": 109,
"start_date_for_period": "2023-01-01",
"value": -70000
},
{
"currency_/_unit": "USD",
"end_character": 129,
"end_date_for_period": "2022-03-31",
"label": "ebit",
"start_character": 126,
"start_date_for_period": "2022-01-01",
"value": -379000
}
] |
10-Q | 0001447028-23-000025 | 20230504160730 | 20230331 | Arbutus Biopharma Corp | The Company recognized $4.1 million and $9.6 million of revenue based on labor hours expended by the Company on its Manufacturing Obligations during the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 27,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 24,
"start_date_for_period": "2023-01-01",
"value": 4099999.9999999995
},
{
"currency_/_unit": "USD",
"end_character": 44,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 41,
"start_date_for_period": "2022-01-01",
"value": 9600000
}
] |
10-Q | 0001120970-23-000033 | 20230502181340 | 20230331 | Comstock Inc. | Revenues from operating leases on our land and building leased to others totaled $30,750 and $54,625 for the three months ended March 31, 2023 and 2022, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 88,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 82,
"start_date_for_period": "2023-01-01",
"value": 30750
},
{
"currency_/_unit": "USD",
"end_character": 100,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 94,
"start_date_for_period": "2022-01-01",
"value": 54625
}
] |
10-Q | 0000082811-23-000092 | 20230509160401 | 20230331 | REGAL REXNORD CORP | The following unaudited supplemental pro forma financial information presents the Company's financial results for the three months ended March 31, 2023 and March 31, 2022, respectively, as if the Altra Transaction had occurred on January 2, 2022, the first day of the Company's fiscal year ended December 31, 2022. The pro forma financial information includes, where applicable, adjustments for: (i) additional amortization expense that would have been recognized related to the acquired intangible assets, (ii) additional interest expense on transaction related borrowings less interest income earned on the investment of proceeds from borrowings prior to the close of the Altra Transaction, (iii) additional depreciation expense that would have been recognized related to the acquired property, plant, and equipment, (iv) transaction costs and other one-time non-recurring costs, including share-based compensation expense related to the accelerated vesting of awards for certain former Altra employees, which reduced expenses by $81.3 million for the three months ended March 31, 2023 and increased expenses by $99.0 million for the three months ended March 31, 2022, (v) additional cost of sales related to the inventory valuation adjustment which increased expenses by $64.2 million for the three months ended March 31, 2022, and (vi) the estimated income tax effect on the pro forma adjustments. | [
{
"currency_/_unit": "USD",
"end_character": 1037,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 1033,
"start_date_for_period": "2023-01-01",
"value": 81300000
},
{
"currency_/_unit": "USD",
"end_character": 1119,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 1115,
"start_date_for_period": "2022-01-02",
"value": 99000000
},
{
"currency_/_unit": "USD",
"end_character": 1279,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 1275,
"start_date_for_period": "2023-01-01",
"value": 64200000
}
] |
10-Q | 0001854401-23-000069 | 20230509162431 | 20230331 | Bridge Investment Group Holdings Inc. | All of the distributable earnings of the Operating Company prior to the IPO were payable to the Original Equity Owners. As of March 31, 2023 and December 31, 2022, there was $0.5 million that was declared that had not yet been distributed to Original Equity Owners. | [
{
"currency_/_unit": "USD",
"end_character": 178,
"end_date_for_period": "2023-03-31",
"label": "eps",
"start_character": 175,
"start_date_for_period": "2023-01-01",
"value": 500000
}
] |
10-Q | 0000067716-23-000066 | 20230504084303 | 20230331 | MDU RESOURCES GROUP INC | The Company recognized revenue from operating leases of $12.2 million and $11.4 million for the three months ended March 31, 2023 and 2022, respectively. At March 31, 2023, the Company had $9.1 million of lease receivables with a majority due within 12 months. | [
{
"currency_/_unit": "USD",
"end_character": 61,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 57,
"start_date_for_period": "2023-01-01",
"value": 12200000
},
{
"currency_/_unit": "USD",
"end_character": 79,
"end_date_for_period": "2022-03-31",
"label": "revenues",
"start_character": 75,
"start_date_for_period": "2022-01-01",
"value": 11400000
},
{
"currency_/_unit": "USD",
"end_character": 193,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 190,
"start_date_for_period": "2023-03-31",
"value": 9100000
}
] |
10-Q | 0001628280-23-016716 | 20230509125247 | 20230331 | Stagwell Inc | Revenue and net income attributable to BNG, included within the three months ended March 31, 2023 Unaudited Consolidated Statements of Operations was $6.6 million and $1.0 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 154,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 151,
"start_date_for_period": "2023-01-01",
"value": 6600000
},
{
"currency_/_unit": "USD",
"end_character": 171,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 168,
"start_date_for_period": "2023-01-01",
"value": 1000000
}
] |
10-Q | 0001628280-23-016716 | 20230509125247 | 20230331 | Stagwell Inc | Revenue and net loss attributable to TMA Direct, included within the three months ended March 31, 2023 Unaudited Consolidated Statements of Operations was $2.6 million and less than $0.1 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 159,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 156,
"start_date_for_period": "2023-01-01",
"value": 2600000
},
{
"currency_/_unit": "USD",
"end_character": 186,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 183,
"start_date_for_period": "2023-01-01",
"value": 100000
}
] |
10-Q | 0001628280-23-016716 | 20230509125247 | 20230331 | Stagwell Inc | Revenue and net loss attributable to Maru, included within the three months ended March 31, 2023 Unaudited Consolidated Statements of Operations was $8.9 million and $2.2 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 153,
"end_date_for_period": "2023-03-31",
"label": "revenues",
"start_character": 150,
"start_date_for_period": "2023-01-01",
"value": 8900000
},
{
"currency_/_unit": "USD",
"end_character": 170,
"end_date_for_period": "2023-03-31",
"label": "XBRL-OOS",
"start_character": 167,
"start_date_for_period": "2023-01-01",
"value": -2200000
}
] |
Subsets and Splits